Member Info for Dibs61

LB28 - the clue is in the wording. Testing for the VIRUS (ie. not antibodies) in the nose and throat. And measuring levels of ANTIBODIES in the blood.

You cannot measure antibodies by a swab!

Mikodx - 98% meets the minimum standard set anyway by PHE. I think the RTC will surpass that level.

ollydolly17 thing is Oxford University have not been working on a Lab Test so far as I am aware. All their efforts have been going into the rapid POC test as part of the RTC

Hi pumpky, do you know what Prof John Bell said of relevance?
cheers

Read those words again carefully. IMO they are significant. She mentions "delighted" "devices" "progressing" "validation" etc etc etc

"Will" make announcements in due course.

I believe this is all being kept very carefully under wraps. They've got something alright.

I took particular note of this comment:

A Department of Health and Social Care spokeswoman said: “We are exploring the use of antibody testing across the NHS and ultimately the wider public.

“We are delighted that devices are progressing through validation, and are actively working on our plans for rolling out antibody testing and will make announcements in due course.”

https://www.bournemouthecho.co.uk/news/national/18448743.frontline-workers-will-first-queue-new-antibody-test/

Do we think that George wants out completely?

People only normally turn up on BB's because they ARE interested, regardless of what they actually say. Apart from the odd weirdo of course.

paolo111 - PHE is an agency of, and run by DHSC which is the government department that set up the UK-RTC. I repeat the DHSC set up the Rapid Test Consortium.

In turn the the DHSC is a government department. Who determines the direction = Government not PHE.

In terms of RISK Roche is a RED HERRING here for us ODX investors. Its a false narrative to suggest that this expensive, and ultimately uncompetitive, LAB test that can only be used by professionals is a threat to over run our potential market. To put it bluntly its TOTAL *******S.

No, its not Roche that is a short term threat to the SP even though its holding it back currently with so much uninformed and nonsensical analysis.

Our RISK is simply that the UK-RTC FAIL to successfully develop a reliable accurate simple to use rapid POC test.

It really is as simple as that. IF that were to happen then other factors come into play such as ODX still manufacturing kits etc but for now its ALL about a successful design freeze and that is what the market is and I think will be focusing on once this Roche distraction has been accurately put in its place.

All this proves is there is going to be a MASSIVE market for Antibody Tests. No one can dispute that now. And there’s will be more than one. Our Test will get there too. Remember all the highly promising remarks recently made by Prof Bell. We have the finest scientific minds working on a more technically challenging test than the Roche one. But we will get there and it will have its place. Ignore the naysayers keep the focus.

Re Roche L-A-B test This is essentially old news now. It’s already out there in the market.

Sorry all you derampers you can huff and you can puff but you won’t blow this house down.

This is such a huge market anyone who believes there will be one winner, one supplier does not understand the rapidly emerging market. There will be different types of antibody tests to serve different markets. No one is disputing lab tests will have an important place in the market but so will POC Tests too.

One thing I did note was that PHE approved this (Roche) test last Thursday but it took nearly a week for the news to leak out..... why?

Thanks Cacher. This was always going to be part of, but not the whole, solution.

I missed that one unv re phe approval. I wouldn't worry about Roche there will be plenty of room in this market for several players (provided their tests are accurate enough). A tiny percentage of the market will be quite enough for ODX revenues to be dramatically transformed. That said I hope and expect we will take more than a tiny percentage.

Cacher - where does it say this Roche LAB test (ie.its NOT an 'antibody test kit') has been passed by PHE. I have seen no such announcement.

And just to repeat it is not an antibody test kit it is a LAB test. You're going to need a helluva lot of trained people to take those 'millions' of blood tests. it's not the same as some bloke handing you a swab to stick up your nose (as with ANTIGEN tests)

up - mmmm interesting

Though why the hell someone didn't spot this little gem until now is beyond me. They already had a world leading product in Visitect CD4 even before Covid. But we knew that didn't we.... ;)

up yes but why no holdings RNS they have to declare above 3%

Not convinced about the leaky ship theory. Not a sharp enough move and not enough heavy buying. There was a definite technical movement around a Fibonacci retracement level @ 45p. But it sure was an impressive intraday reversal. A sign of what could be coming.

The other mystery to me is that I’ve been convinced we have a constant background seller due to the repeating trading patterns day in day out. But no Holdings RNS’s since start of the month? And what about the huge volume over the past few weeks? So many questions.

It did feel though that something changed at lunchtime today. Whether it was the seller finishing or the schools announcement or some kind of leak. The SP trading pattern this afternoon was notably different than the past several days.

I will still be surprised if we see an announcement tomorrow but let’s see what the day brings.

It was a very quiet board before all this! I got a bit concerned that this BB was getting 'over-board' if you'll pardon the pun. However it's actually settled down a bit while the SP has dropped and yes you've still got some nervousness understandably from some particularly if you have a high average and you're down. Let's accept reasonable challenging questions - you can tell the ones who are either too stupid or have a negative agenda.

There's no magic answer in these situations you either hold and be patient or you sell.

I believe it is 25p but you should bear in mind they have not yet factored in ANY Covid Revenues because they wanted more visibility before they rerated.

So that valuation is purely based on Vistect Cd4 and Food Intolerance (not yet any revenues for Allergy)